HawkEye 360 enters the final stretch of the quarter with falling analyst price targets, a put-heavy options market, and insiders selling into the slide, all while the stock has lost more than 20% in a month.
The Street's direction of travel is clearly lower, even as the underlying ratings hold. RBC Capital's Ken Herbert cut his target to $28 from $33 on September 30, keeping his Outperform rating intact. B of A Securities upgraded to Buy on September 17 but simultaneously slashed its target from $34 to $23, an unusual combination that reads as a cautious catch, not a conviction call. Jefferies trimmed to $31 from $34 in August, also retaining Buy. The consensus mean price target now sits at $32, more than double the current $15.38 close, a gap that reflects how far the stock has fallen since analysts initiated coverage in June rather than any specific near-term catalyst. Craig-Hallum and Raymond James both launched with Buy-equivalent ratings in July and June respectively, so the coverage base is still new and targets remain anchored to the original thesis rather than revised post-decline figures.
Options positioning tells a similarly cautious story. The put/call ratio has climbed to 1.62, running well above its 20-day average of 1.34, and has been elevated for most of September after a sharp rotation from call-heavy to put-heavy positioning that began in early September. At the start of August the ratio was below 0.25; it has more than quintupled since. The ratio is approaching its 52-week high of 1.70, meaning demand for downside protection is close to its most extreme level of the past year.
The lending market shows less stress than the options picture might imply. Borrow availability has loosened dramatically, jumping to 308% from around 115% a week ago. That means roughly three shares are available to borrow for every one already shorted, a notably loose market compared to the 52-week tightest reading of 45%. Cost to borrow has also eased, falling to 1.05% from 1.49% two weeks ago. Short interest itself is up about 14% over the past month to around 4.2 million shares, but with no free-float percentage calculable from the available data and the ORTEX short score dropping sharply to 52 from 60 earlier in the week, the short-selling pressure looks more like a moderate lean than an aggressive pile-in. The positioning reads as cautious rather than crowded.
Insider activity adds a layer worth noting. The 90-day net is negative, with roughly $1.4 million in net selling. The CFO sold $150,000 of stock on September 15 in an open-market transaction not tied to a 10b5-1 plan, making it a discretionary sale. A director sold $820,500 on September 11, also off-plan, though that transaction was paired with an option exercise at $0.23 per share. The Chief Legal Officer's two sales in September were both under a 10b5-1 plan, carrying less signal. On the ownership side, the three largest holders, Insight Holdings at 14.5%, David G. DeWalt at 9.3%, and GIC Private Limited at 7.1%, are all on Schedule 13G filings indicating passive stakes, with no 13D activist on the register. Insight and DeWalt's filings are as of August 14 and GIC's as of May 12, so these positions are as last disclosed.
One data point sits outside the fundamental picture: Wikipedia and ORTEX page views for HawkEye 360 registered a retail attention z-score of 5.9 as of September 21, the highest reading in the available window. That is an attention signal, not a revenue or sentiment indicator, but it suggests the stock is drawing more retail eyeballs than usual, likely because of the size of the drawdown rather than any positive catalyst.
With the next earnings event scheduled for November 13, the stock now has six weeks to either stabilise on contract news or continue repricing toward the revised analyst targets. The question heading into that print is whether the gap between a $15 stock and a $28-to-$32 analyst target narrows on new fundamental evidence, or whether targets follow the stock lower.
See the live data behind this article on ORTEX.
Open HAWK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
